Sarecycline

DRUG7 trials

Sponsors

Almirall, S.A., Derm Research, PLLC, Angela Moore, Integrative Skin Science and Research

Conditions

Acne RosaceaAcne Vulgaris

Phase 3

Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

CompletedNCT02320149

Almirall, S.A.Acne Vulgaris

Start: 2014-12-18End: 2017-02-01Updated: 2019-02-15

Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

CompletedNCT02322866

Almirall, S.A.Acne Vulgaris

Start: 2014-12-03End: 2017-01-12Updated: 2019-02-01

A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris

CompletedNCT02413346

Almirall, S.A.Acne Vulgaris

Start: 2015-03-20End: 2016-08-26Updated: 2019-02-01

Phase 4

A Pilot Study on the Use of Seysara for Rosacea

CompletedNCT04555525

Derm Research, PLLCAcne Rosacea

Start: 2019-04-15End: 2020-10-01Updated: 2021-01-07

Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.

RecruitingNCT07544251

Integrative Skin Science and ResearchAcne Vulgaris

Start: 2026-04-20End: 2027-06-01Target: 30Updated: 2026-04-22

Unknown Phase

Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)

CompletedNCT04820673

Almirall, S.A.Acne Vulgaris

Start: 2021-03-09End: 2022-05-04Updated: 2024-10-10

Sarecycline Truncal Acne Safety and Efficacy Response

CompletedNCT05010538

Angela MooreAcne Vulgaris

Start: 2021-03-09End: 2021-08-31Updated: 2023-08-01

Related Papers

Acne symptoms and impact of acne on social functioning, emotional functioning, and activities of daily living (ADL) among patients with moderate to severe non-nodular Acne Vulgaris (AV) in community practices across the U.S

SKIN The Journal of Cutaneous Medicine2023-05-20